Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis

OBJECTIVE: To evaluate the cost effectiveness of four disease modifying treatments (interferon betas and glatiramer acetate) for relapsing remitting and secondary progressive multiple sclerosis in the United Kingdom. DESIGN: Modelling cost effectiveness. SETTING: UK NHS. PARTICIPANTS: Patients with...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Chilcott, Jim, McCabe, Chris, Tappenden, Paul, O'Hagan, Anthony, Cooper, Nicola J, Abrams, Keith, Claxton, Karl
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Group 2003
Soggetti:
Papers
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC150460/
https://ncbi.nlm.nih.gov/pubmed/12623909
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi